We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Pfizer | LSE:PFZ | London | Ordinary Share | COM STK USD0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.78 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMPFZ
RNS Number : 2057A
Pfizer Inc
23 March 2017
Cancellation of Listing
23 March 2017
Pfizer Inc. (NYSE:PFE) (the "Company") announces that at 8:00 a.m. (London time) today, the United Kingdom Listing Authority ("UKLA") cancelled the standard listing of the Company's common stock ("Common Stock") from the Official List of the UKLA and the London Stock Exchange ("LSE") cancelled the trading of the Company's Common Stock on the Main Market of the LSE.
The Company will continue to list its Common Stock on the New York Stock Exchange under the symbol "PFE".
***
Contact
Media:
Joan Campion, + 1.212-733-2798
Joan.Campion@pfizer.com
Investor:
Chuck Triano, +1 212-733-3901
Charles.E.Triano@pfizer.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSEDFFEFWSEED
(END) Dow Jones Newswires
March 23, 2017 04:17 ET (08:17 GMT)
1 Year Pfizer Chart |
1 Month Pfizer Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions